INSM Stock Analysis: Buy, Sell, or Hold?
INSM - Insmed, Inc.
$162.43
-2.43 (-1.47%)
▼
5d:
+10.05%
30d:
+8.37%
90d:
-6.67%
BUY
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
INSM is down 7.0% this week, but smart money is accumulating calls. Top strike: $165 2026-04-17 with 2,222 OI. Call ratio: 93% View Scanner →
Strength: 7.8/10
Get Alerted When INSM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: INSM shows positive signals but monitor for confirmation. Market pricing in 13.0% decline. Moderate conviction.
💡 BUY OPPORTUNITY: INSM shows positive signals but monitor for confirmation. Market pricing in 13.0% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$23.44
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$14.55
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INSM is currently trading at $162.43, which is considered extended relative to its 30-day fair value range of $139.93 to $155.07. From a valuation perspective, the stock is trading at a discount (Forward PE: 242.8) compared to its historical average (368.3). Remarkably, the market is currently pricing in an annual earnings decline of 13.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, INSM is in a strong downtrend. The price is approaching resistance at $166.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: INSM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $214.32 (+31.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INSM is in a strong downtrend. The price is approaching resistance at $166.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: INSM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $214.32 (+31.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$139.93 -
$155.07
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 31.9% below Wall St target ($214.32)
Fair Price Analysis
30-Day Fair Range
$139.93 -
$155.07
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$135.73
Resistance Level
$166.00
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
242.76
Wall Street Target
$214.32
(+31.9%)
Revenue Growth (YoY)
152.6%
Profit Margin
-210.5%
Valuation Discount vs History
-13.0% cheaper
PE vs Historical
242.8 vs 368.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.0%
(market-implied from PE analysis)
1-Year Target
$146.19
(-10%)
2-Year Target
$131.57
(-19%)
3-Year Target
$118.41
(-27%)
3-Yr Target (if PE normalizes)
(PE: 243→368)
$179.65
(+11%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 242.8 to 368.3
Stabilization Target:
$246.43
(+51.7%)
PE Expansion Potential:
+51.7%
Share & Embed Analysis
Last updated: April 02, 2026 11:42 PM ET
Data refreshes hourly during market hours. Next update: 12:42 AM
Data refreshes hourly during market hours. Next update: 12:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INSM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
William Lewis
SELL
10699 shares
2026-03-05
William Lewis
SELL
10699 shares
2026-02-19
William Lewis
SELL
13396 shares
2026-02-09
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 62 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 62 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 66 BUY |
Advanced INSM Option Strategies
Professional options setups generated by AI based on today's INSM price and gamma walls.
